Impact of dexamethasone responsiveness on long-term outcome in patients with newly diagnosed myeloma

被引：0
|
作者：
Sinha, S. [1 ]
Rajkumar, S. V. [1 ]
Lacy, M. [1 ]
Hayman, S. [1 ]
Baudi, F. [1 ]
Dispenzieri, A. [1 ]
Lust, J. [1 ]
Greipp, P. [1 ]
Gertz, M. [1 ]
Kumar, S. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8603
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
    Sinha, Shirshendu
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Dingli, David
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) : 853 - 858
  • [2] The Impact of Age in the Long-Term Outcome of Patients with Newly Diagnosed Multiple Myeloma
    Garcia, A.
    Sureda, A.
    Canas, C.
    Lahuerta, J. J.
    De la Rubia, J.
    Garcia-Sanz, R.
    Martinez, R.
    Garcia-Larana, J.
    de Arriba, F.
    Ribera, J. M.
    Hernandez, M.
    Escoda, L.
    Carrera, D.
    Terol, M. J.
    Besalduch, J.
    Casado, F.
    Blade, J.
    Miguel, J. San
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S79 - S79
  • [3] Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
    G Srivastava
    V Rana
    M Q Lacy
    F K Buadi
    S R Hayman
    A Dispenzieri
    M A Gertz
    D Dingli
    S Zeldenrust
    S Russell
    A McCurdy
    P Kapoor
    R Kyle
    S V Rajkumar
    S Kumar
    [J]. Leukemia, 2013, 27 : 2062 - 2066
  • [4] Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
    Srivastava, G.
    Rana, V.
    Lacy, M. Q.
    Buadi, F. K.
    Hayman, S. R.
    Dispenzieri, A.
    Gertz, M. A.
    Dingli, D.
    Zeldenrust, S.
    Russell, S.
    McCurdy, A.
    Kapoor, P.
    Kyle, R.
    Rajkumar, S. V.
    Kumar, S.
    [J]. LEUKEMIA, 2013, 27 (10) : 2062 - 2066
  • [5] Impact of Hematologic Parameters in Newly Diagnosed Multiple Myeloma Patients on Long-Term Outcomes
    Joseph, Nisha
    Nooka, Ajay
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S257 - S257
  • [6] Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma
    Reeder, Craig B.
    Reece, Donna E.
    Kukreti, Vishal
    Mikhael, Joseph R.
    Chen, Christine
    Trudel, Suzanne
    Laumann, Kristina
    Vohra, Harjot
    Fonseca, Rafael
    Bergsagel, P. Leif
    Leis, Jose F.
    Tiedemann, Rodger
    Stewart, A. Keith
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) : 563 - 565
  • [7] Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
    T V Kourelis
    S K Kumar
    G Srivastava
    M A Gertz
    M Q Lacy
    F K Buadi
    R A Kyle
    A Dispenzieri
    [J]. Leukemia, 2014, 28 : 455 - 457
  • [8] Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
    Kourelis, T. V.
    Kumar, S. K.
    Srivastava, G.
    Gertz, M. A.
    Lacy, M. Q.
    Buadi, F. K.
    Kyle, R. A.
    Dispenzieri, A.
    [J]. LEUKEMIA, 2014, 28 (02) : 455 - 457
  • [9] Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myeloma
    Gassiot, Susanna
    Motllo, Cristina
    Llombart, Inuska
    Morgades, Mireia
    Gonzalez, Yolanda
    Garcia-Caro, Montse
    Ribera, Josep-Maria
    Oriol, Albert
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (06) : 569 - 576
  • [10] Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomesMULTIPLE MYELOMA, GAMMOPATHIES
    Thierry Facon
    Philippe Moreau
    Katja Weisel
    Hartmut Goldschmidt
    Saad Z. Usmani
    Ajai Chari
    Torben Plesner
    Robert Z. Orlowski
    Nizar Bahlis
    Supratik Basu
    Cyrille Hulin
    Hang Quach
    Michael O’Dwyer
    Aurore Perrot
    Caroline Jacquet
    Christopher P. Venner
    Noopur Raje
    Mourad Tiab
    Margaret Macro
    Laurent Frenzel
    Xavier Leleu
    Gordon Cook
    George Wang
    Huiling Pei
    Maria Krevvata
    Robin Carson
    Fredrik Borgsten
    Shaji K. Kumar
    [J]. Leukemia, 2025, 39 (4) : 942 - 950
12345